PortViewPortView
CARGO Therapeutics logo

CARGO Therapeutics (CRGX) Stock Analysis

NASDAQHealthcareBiotechnology

$4.47+0.00%
1-year price historyRange $3.39 – $25.00
52-week range$4.47
$3.00$25.45

What CARGO Therapeutics does

CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.

Key metrics

Market cap
$216.19M
P/E (TTM)
-0.97
EPS (TTM)
$-4.62
Beta
0.29
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$4.45
200-day avg
$7.81
52-week high
$25.45
52-week low
$3.00
CEO
Anup Radhakrishnan

ETFs linked to CRGX

Broad-market and Healthcare sector ETFs an investor holding CARGO Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CRGX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CRGX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for CARGO Therapeutics?
CARGO Therapeutics trades under the ticker CRGX on NASDAQ.
Which exchange is CRGX listed on?
CRGX is listed on NASDAQ.
What sector does CARGO Therapeutics operate in?
CARGO Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CRGX in a portfolio?
PortView shows CRGX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.